Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Ronhjones
m (subst:'ing, replaced: {{•}} →  • (35) using AWB)
blackwiki>Anypodetos
m (Simplify markup, replaced:  • →  • (35) using AWB)
Line 9: Line 9:
  
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
|  list1 = [[Abciximab]] •  [[Eptifibatide]] •  [[Tirofiban]]
+
|  list1 = [[Abciximab]]  [[Eptifibatide]]  [[Tirofiban]]
  
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] inhibitors
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] inhibitors
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]])&#160;&#8226;  [[Ticagrelor]]<sup>†</sup>
+
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]])&nbsp; [[Ticagrelor]]<sup>†</sup>
  
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
|  list3 = [[Beraprost]]&#160;&#8226;  [[Prostacyclin]]&#160;&#8226;  [[Iloprost]]&#160;&#8226;  [[Treprostinil]]
+
|  list3 = [[Beraprost]]&nbsp; [[Prostacyclin]]&nbsp; [[Iloprost]]&nbsp; [[Treprostinil]]
  
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>&#160;&#8226;  [[Aloxiprin]]&#160;&#8226;  [[Carbasalate calcium]]&#160;&#8226;  [[Indobufen]]&#160;&#8226;  [[Triflusal]]
+
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>&nbsp; [[Aloxiprin]]&nbsp; [[Carbasalate calcium]]&nbsp; [[Indobufen]]&nbsp; [[Triflusal]]
  
 
| group5 = [[Thromboxane]] inhibitors
 
| group5 = [[Thromboxane]] inhibitors
|  list5 = ''[[thromboxane synthase]] inhibitors'' ([[Dipyridamole]], [[Picotamide]])&#160;&#8226;  ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
+
|  list5 = ''[[thromboxane synthase]] inhibitors'' ([[Dipyridamole]], [[Picotamide]])&nbsp; ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
  
 
| group6 = [[Phosphodiesterase inhibitor]]s
 
| group6 = [[Phosphodiesterase inhibitor]]s
|  list6 = [[Cilostazol]]&#160;&#8226;  [[Dipyridamole]]&#160;&#8226;  [[Triflusal]]
+
|  list6 = [[Cilostazol]]&nbsp; [[Dipyridamole]]&nbsp; [[Triflusal]]
  
 
| group7 = Other  
 
| group7 = Other  
|  list7 = [[Cloricromen]]&#160;&#8226;  [[Ditazole]]
+
|  list7 = [[Cloricromen]]&nbsp; [[Ditazole]]
  
 
}}
 
}}
Line 36: Line 36:
  
 
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
 
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]&#160;&#8226;  [[Coumatetralyl]]&#160;&#8226;  [[Dicoumarol]]&#160;&#8226;  [[Ethyl biscoumacetate]]&#160;&#8226;  [[Phenprocoumon]]&#160;&#8226;  [[Warfarin]]
+
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]&nbsp; [[Coumatetralyl]]&nbsp; [[Dicoumarol]]&nbsp; [[Ethyl biscoumacetate]]&nbsp; [[Phenprocoumon]]&nbsp; [[Warfarin]]
  
''[[1,3-Indandione]]s:'' [[Clorindione]]&#160;&#8226;  [[Diphenadione]]&#160;&#8226;  [[Phenindione]]
+
''[[1,3-Indandione]]s:'' [[Clorindione]]&nbsp; [[Diphenadione]]&nbsp; [[Phenindione]]
  
 
''other:'' [[Tioclomarol]]  
 
''other:'' [[Tioclomarol]]  
Line 61: Line 61:
 
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
 
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
  
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]&#160;&#8226;  [[Dabigatran]]&#160;&#8226;  [[Melagatran]]<sup>‡</sup>&#160;&#8226;  [[Ximelagatran]]<sup>‡</sup>
+
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]&nbsp; [[Dabigatran]]&nbsp; [[Melagatran]]<sup>‡</sup>&nbsp; [[Ximelagatran]]<sup>‡</sup>
  
 
| group8 = Other  
 
| group8 = Other  
|  list8 = [[REG1<!--instantly reversible aptamer based direct FIXa inhibitor in IIb trials -->]]&#160;&#8226; [[Defibrotide]]&#160;&#8226;  [[Ramatroban]]&#160;&#8226;  [[Antithrombin|Antithrombin III]]&#160;&#8226;  [[Protein C]] ([[Drotrecogin alfa]])
+
|  list8 = [[REG1<!--instantly reversible aptamer based direct FIXa inhibitor in IIb trials -->]]&nbsp;[[Defibrotide]]&nbsp; [[Ramatroban]]&nbsp; [[Antithrombin|Antithrombin III]]&nbsp; [[Protein C]] ([[Drotrecogin alfa]])
  
 
}}
 
}}
  
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
|  list5 = ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]])&#160;&#8226;  ''UPA'' ([[Urokinase]], [[Saruplase]])&#160;&#8226;  [[Streptokinase]]<sup>#</sup>&#160;&#8226;  [[Anistreplase]]&#160;&#8226;  [[Monteplase]]
+
|  list5 = ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]])&nbsp; ''UPA'' ([[Urokinase]], [[Saruplase]])&nbsp; [[Streptokinase]]<sup>#</sup>&nbsp; [[Anistreplase]]&nbsp; [[Monteplase]]
  
''other [[serine endopeptidase]]s:'' [[Ancrod]]&#160;&#8226;  [[Fibrinolysin]]
+
''other [[serine endopeptidase]]s:'' [[Ancrod]]&nbsp; [[Fibrinolysin]]
  
 
[[Brinase]]
 
[[Brinase]]
Line 77: Line 77:
  
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
|  list8 = [[Citrate]]&#160;&#8226;  [[EDTA]]&#160;&#8226;  [[Oxalate]]
+
|  list8 = [[Citrate]]&nbsp; [[EDTA]]&nbsp; [[Oxalate]]
  
 
| group9 =  
 
| group9 =  

Revision as of 09:07, 3 January 2011